MIT Technology Review @techreview
-Most covid-19 vaccines in late-stage clinical trials look like they're going to be double-dose -We have no idea right now about long-term protections -We're likely to have efficacy results this quarter -We should begin to see vaccines rolled out through an EUA next year — PolitiTweet.org